IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
about
Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms.Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.Prognostic value of high IMP3 expression in solid tumors: a meta-analysisExpression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinomaOverexpression of eIF3e is correlated with colon tumor development and poor prognosis.Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodulesEnhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma ProgressionMusashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stageOverexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancerInsulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes.Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosisDecreased MALL expression negatively impacts colorectal cancer patient survivalIMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.High-level expression of P21-Cdc/Rac-activated kinase 7 is closely related to metastatic potential and poor prognosis of colon carcinoma.IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis.IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells.Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.Ciz1 is a novel predictor of survival in human colon cancer.Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression.Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer.
P2860
Q31121056-1C3D2055-FA51-43A2-A2D0-8FD191064D18Q33274978-53A40721-E67A-478B-B6E2-BD254E8658A6Q33598498-45F33E8D-EB2E-4168-AD4A-F616B12A2763Q33621918-E9081C1B-142E-4365-9C58-B6C4E22EE504Q33813288-AFAA3D93-F597-4C2D-B499-42C9CC107F68Q34293287-9D261383-24BA-4094-8A86-7A47FC8ED8EEQ34502089-68B81375-303E-49ED-AD5C-192850394F40Q35110943-8CD4603E-5508-413F-BF87-F7DF7DDDD082Q35125481-35ACFB37-6982-4941-AB4D-0D6A65217337Q35546846-D7987E7B-E174-459E-8182-069750023822Q35666438-8FED4547-B2C4-47A4-A85F-46B8F2B4A964Q35863071-39FA7446-E1A2-4359-BBA3-4A796A79C4B7Q35916537-0B0FDA8E-BB19-4651-B46C-0A660791D8EBQ36261604-698384AE-1359-4CE4-B982-E907E8AEA01CQ36334142-740F73CA-ABAE-49FD-BF0C-4D6FC9838B4EQ36377476-071AC3F9-CE9E-4FB5-ABDE-BD146A61B1E7Q36517288-3D3E0C0F-FE81-4CEC-9883-240578EA1BCBQ36723387-FB51EE56-DB5B-4218-AE87-730A5176B8D1Q36733283-94B12822-1C46-4E84-9C57-4C85137B908FQ36983845-C34A9CF5-07E5-499F-BB20-A2E7DBABAA5AQ37002361-5CF033DF-B56C-4FD2-B3E3-05BC6D9E4126Q37054556-D96DA7EA-C317-48A6-AA65-94A3A1404DC1Q37225710-7F6EB66F-C4C1-499F-8CC6-ED6890A8BBA5Q37262152-E9E96CF1-354F-4A6E-998E-E6AB7B260BABQ37328136-43C1AFA2-CF81-4C83-86C3-17E59248BF6BQ37564643-407EB01F-EE9A-40BD-9846-0A57B03720C8Q37747546-5EF02213-A2CB-4281-8D10-46DAA95CD38BQ38816572-B278BB76-09D9-4E19-8758-1803A7758D86Q39090006-735AD2D2-1A26-4415-A863-98237F5A9713Q39252472-8B4F892E-F729-48EF-8002-9A6E2C258A32Q39276310-DEAB2A57-BC4D-416E-A79D-0CCE7EA3295BQ41123932-D917628A-BBC6-4349-A46C-707FB5B7311EQ43527311-5BD00000-4075-431B-AE45-1EC798686614Q44585258-7F613815-6F8C-445E-8FD1-51B34ABE9AE4Q44913105-C6148A96-26FC-498E-BD4E-79DA5F28AD6EQ45042803-3B21FE72-88A2-4408-AE17-5759D91945ACQ47094355-83559657-92FF-447F-BD2D-F8A21482B2B3Q47426765-5A00D404-92CF-45D1-878B-FD8FDD8C7F7EQ47908285-749A27E8-9B3B-4EA0-B3CA-6504D12BBBAAQ49187441-6963BAA6-EDE5-4624-822C-0150107A80C8
P2860
IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@en
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@nl
type
label
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@en
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@nl
prefLabel
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@en
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@nl
P2093
P1476
IMP3 is a novel prognostic mar ...... progression and pathogenesis.
@en
P2093
Chongzhi Zhou
Dongwang Yan
Guoqiang Qiu
Huamei Tang
Junwei Fan
Xiaoliang Wang
P2888
P304
P356
10.1245/S10434-009-0648-5
P577
2009-12-01T00:00:00Z
P6179
1011666092